The FDA, PBMs and the COVID-19 Pandemic
There has been a lot of information on COVID-19 treatments and therapies and how quickly they will come to market. Our Chief Medical Officer, Dr. Caroline Carney, sat down to answer some key questions about COVID-19, the FDA and PBMs.
Don't Get Left Out!
Be the first to receive new reports, product updates and industry insights straight to your inbox!